Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia

This single-blind, placebo-controlled experiment (n=20) showed how ketamine decreased mismatch negativity (MMN), offering insights into how this neurological system may influence information processing in schizophrenia.

Abstract of Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers

Background: In patients with schizophrenia, deficient generation of mismatch negativity (MMN)—an event-related potential (ERP) indexing auditory sensory (“echoic”) memory—and a selective increase of “context-dependent” (“BX”) errors in the “A-X” version of the Continuous Performance Test (AX-CPT) indicate an impaired ability to form and use transient memory traces. Animal and human studies implicate deficient N-methyl-D-aspartate receptor (NMDAR) functioning in such abnormalities. In this study, the effects of the NMDAR antagonists ketamine on MMN generation and AX-CPT performance were investigated in healthy volunteers to test the hypothesis that NMDARs are critically involved in human MMN generation and to assess the nature of ketamine-induced deficits in AX-CPT performance.

Methods: In a single-blind, placebo-controlled study, 20 healthy volunteers underwent an infusion with subanesthetic doses of ketamine. The MMN-to-pitch and MMN-to-duration deviants were obtained while subjects performed an AX-CPT.

Results: Ketamine significantly decreased the peak amplitudes of the MMN-to-pitch and MMN-to-duration deviants by 27% and 21%, respectively. It induced performance deficits in the AX-CPT characterized by decreased hit rates and specific increases of errors (BX errors), reflecting a failure to form and use transient memory traces of task-relevant information.

Conclusions: The NMDARs are critically involved in human MMN generation. Deficient MMN in schizophrenia thus suggests deficits in NMDAR-related neurotransmission. N-methyl-D-aspartate receptor dysfunction may also contribute to the impairment of patients with schizophrenia in forming and using transient memory traces in more complex tasks, such as the AX-CPT. Thus, NMDAR-related dysfunction may underlie deficits in transient memory at different levels of information processing in schizophrenia.”

Authors: Daniel Umbricht, Liselotte Schmid & Rene Koller

Summary of Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers

Deficient N-methyl-D-aspartate (NMDAR) – dependent neurotransmission may contribute to cognitive deficits in schizophrenia, including deficits in transient memory and impaired performance in tasks that tax transient maintenance of information.

To access this content, you must purchase one of the following memberships: Pro Membership, Pro Membership Unlimited, Business Membership or Business Membership Unlimited. The membership will give you access to exclusive data, including summaries of psychedelic research papers, extended company info, and our member-only visualisations. Save yourself multiple hours each week by accessing Blossom’s resource library.

Find this paper

Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia

https://doi.org/10.1001/archpsyc.57.12.1139

Open Access | Google Scholar | Backup | 🕊

Cite this paper (APA)

Umbricht, D., Schmid, L., Koller, R., Vollenweider, F. X., Hell, D., & Javitt, D. C. (2000). Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Archives of general psychiatry57(12), 1139-1147.

Study details

Compounds studied
Ketamine

Topics studied
Schizophrenia

Study characteristics
Placebo-Controlled Single-Blind Randomized

Participants
20 Humans

PDF of Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia